Want to join the conversation?
$HAS said while the UK Brexit vote has created some near-term uncertainty and negatively impacted its currency, the company has positive momentum in both the UK and in Europe heading into 2H16. The company also stated that to date it has not seen a negative impact on its business.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.